✦ LIBER ✦

Flavopiridol: the First Cyclin-Dependent Kinase Inhibitor in Human Clinical Trials

✍ Scribed by Adrian M. Senderowicz

Book ID: 110234545
Publisher: Springer US
Year: 1999
Tongue: English
Weight: 83 KB
Volume: 17
Category: Article
ISSN: 0167-6997
DOI: 10.1023/a:1006353008903

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I clinical and pharmacokinetic tri

Phase I clinical and pharmacokinetic trial of the cyclin-dependent kinase inhibitor flavopiridol

✍ James P. Thomas; Kendra D. Tutsch; James F. Cleary; Howard H. Bailey; Rhoda Arzo 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 252 KB

A phase I clinical trial of FOLFIRI in c

A phase I clinical trial of FOLFIRI in combination with the pan-cyclin-dependent kinase (CDK) inhibitor flavopiridol

✍ Mark A. Dickson; Manish A. Shah; Dana Rathkopf; Archie Tse; Richard D. Carvajal; 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 392 KB

Phase II trial of flavopiridol, a cyclin

Phase II trial of flavopiridol, a cyclin dependent kinase inhibitor, in untreated metastatic malignant melanoma

✍ Susan Burdette-Radoux; Richard G. Tozer; Reinhard C. Lohmann; Ian Quirt; D. Scot 📂 Article 📅 2004 🏛 Springer US 🌐 English ⚖ 70 KB

Expression of cyclin-dependent kinase in

Expression of cyclin-dependent kinase inhibitor p21 in human liver

✍ Gretchen S. Crary; Jeffrey H. Albrecht 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 257 KB

The p21 protein is a universal inhibitor of cyclindependent kinases and of cell-cycle progression and is involved in numerous growth-inhibitory pathways in cell culture systems. Recent studies suggest that p21 regulates hepatocyte cell cycle progression in models of liver regeneration. The present s

Molecular analysis of cyclin-dependent k

Molecular analysis of cyclin-dependent kinase inhibitors in human leukemias

✍ Hayette, S; Thomas, X; Bertrand, Y; Tigaud, I; Callanan, M; Thiebaut, A; Charrin 📂 Article 📅 1997 🏛 Nature Publishing Group 🌐 English ⚖ 322 KB

The cyclin-dependent kinase inhibitor fl

The cyclin-dependent kinase inhibitor flavopiridol induces apoptosis in human leukemia cells (U937) through the mitochondrial rather than the receptor-mediated pathway

✍ Decker, R H; Dai, Y; Grant, S 📂 Article 📅 2001 🏛 Nature Publishing Group 🌐 English ⚖ 226 KB